| Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe M Souli, I Galani, H Giamarellou Eurosurveillance 13 (47), 2008 | 725 | 2008 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 478 | 2017 |
| An Outbreak of Infection due to â-Lactamase Klebsiella pneumoniae Carbapenemase 2–Producing K. pneumoniae in a Greek University Hospital: Molecular … M Souli, I Galani, A Antoniadou, E Papadomichelakis, G Poulakou, ... Clinical infectious diseases 50 (3), 364-373, 2010 | 437 | 2010 |
| Treating infections caused by carbapenemase-producing Enterobacteriaceae LS Tzouvelekis, A Markogiannakis, E Piperaki, M Souli, GL Daikos Clinical Microbiology and Infection 20 (9), 862-872, 2014 | 401 | 2014 |
| Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control Y Carmeli, M Akova, G Cornaglia, GL Daikos, J Garau, S Harbarth, ... Clinical Microbiology and Infection 16 (2), 102-111, 2010 | 364 | 2010 |
| Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster A Antoniadou, F Kontopidou, G Poulakou, E Koratzanis, I Galani, ... Journal of Antimicrobial Chemotherapy 59 (4), 786-790, 2007 | 323 | 2007 |
| Metallo-â-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues G Cornaglia, M Akova, G Amicosante, R Cantón, R Cauda, JD Docquier, ... International journal of antimicrobial agents 29 (4), 380-388, 2007 | 236 | 2007 |
| Colistin susceptibility testing by Etest and disk diffusion methods I Galani, F Kontopidou, M Souli, PD Rekatsina, E Koratzanis, J Deliolanis, ... International journal of antimicrobial agents 31 (5), 434-439, 2008 | 205 | 2008 |
| Evaluation of different laboratory tests for the detection of metallo-â-lactamase production in Enterobacteriaceae I Galani, PD Rekatsina, D Hatzaki, D Plachouras, M Souli, H Giamarellou Journal of antimicrobial chemotherapy 61 (3), 548-553, 2008 | 200 | 2008 |
| European handbook of dermatological treatments AD Katsambas, TM Lotti, C Dessinioti, D Angelo Massimiliano Springer, 1999 | 188 | 1999 |
| ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers E Tacconelli, F Mazzaferri, AM de Smet, D Bragantini, P Eggimann, ... Clinical microbiology and infection 25 (7), 807-817, 2019 | 172 | 2019 |
| Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection C Gogos, A Kotsaki, A Pelekanou, G Giannikopoulos, I Vaki, P Maravitsa, ... Critical Care 14, 1-12, 2010 | 170 | 2010 |
| Effects of slime produced by clinical isolates of coagulase-negative staphylococci on activities of various antimicrobial agents M Souli, H Giamarellou Antimicrobial agents and chemotherapy 42 (4), 939-941, 1998 | 170 | 1998 |
| In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals M Souli, FV Kontopidou, E Koratzanis, A Antoniadou, E Giannitsioti, ... Antimicrobial agents and chemotherapy 50 (9), 3166-3169, 2006 | 168 | 2006 |
| A multinational, preregistered cohort study of â-lactam/â-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-â-lactamase … B Gutiérrez-Gutiérrez, S Perez-Galera, E Salamanca, M De Cueto, ... Antimicrobial agents and chemotherapy 60 (7), 4159-4169, 2016 | 167 | 2016 |
| Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-â-lactamase in a Greek university hospital M Souli, FV Kontopidou, E Papadomichelakis, I Galani, A Armaganidis, ... Clinical infectious diseases 46 (6), 847-854, 2008 | 151 | 2008 |
| In Vitro Interactions of Antimicrobial Combinations with Fosfomycin against KPC-2-Producing Klebsiella pneumoniae and Protection of Resistance Development M Souli, I Galani, S Boukovalas, MG Gourgoulis, Z Chryssouli, ... Antimicrobial agents and chemotherapy 55 (5), 2395-2397, 2011 | 148 | 2011 |
| Colistin: still a lifesaver for the 21st century? I Karaiskos, M Souli, I Galani, H Giamarellou Expert opinion on drug metabolism & toxicology 13 (1), 59-71, 2017 | 124 | 2017 |
| Activity of Plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece I Galani, M Souli, GL Daikos, Z Chrysouli, G Poulakou, M Psichogiou, ... Journal of Chemotherapy 24 (4), 191-194, 2012 | 122 | 2012 |
| Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci V Sakka, S Tsiodras, L Galani, A Antoniadou, M Souli, I Galani, ... Clinical Microbiology and Infection 14 (1), 14-21, 2008 | 120 | 2008 |
Helen GiamarellouProfessor of Internal Medicine, National and Kapodistrian University of Athens, Medical SchoolVerified email at med.uoa.gr
